126 related articles for article (PubMed ID: 23182790)
1. [Illegal abortion with misoprostol in Guadeloupe].
Manouana M; Kadhel P; Koffi A; Janky E
J Gynecol Obstet Biol Reprod (Paris); 2013 Apr; 42(2):137-42. PubMed ID: 23182790
[TBL] [Abstract][Full Text] [Related]
2. A six month prospective study on different aspects of abortion.
Madebo T; G/Tsadic T
Ethiop Med J; 1993 Jul; 31(3):165-72. PubMed ID: 8404881
[TBL] [Abstract][Full Text] [Related]
3. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy.
Gonzalez CH; Marques-Dias MJ; Kim CA; Sugayama SM; Da Paz JA; Huson SM; Holmes LB
Lancet; 1998 May; 351(9116):1624-7. PubMed ID: 9620717
[TBL] [Abstract][Full Text] [Related]
4. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
[TBL] [Abstract][Full Text] [Related]
5. Commercial availability of misoprostol and induced abortion in Brazil.
Costa SH
Int J Gynaecol Obstet; 1998 Dec; 63 Suppl 1():S131-9. PubMed ID: 10075223
[TBL] [Abstract][Full Text] [Related]
6. A prospective survey of cases of complications of induced abortion presenting to Goroka Hospital, Papua New Guinea, 2011.
Asa I; de Costa C; Mola G
Aust N Z J Obstet Gynaecol; 2012 Oct; 52(5):491-3. PubMed ID: 22694099
[TBL] [Abstract][Full Text] [Related]
7. Neonatal morbidity and outcome of live born premature babies after attempted illegal abortion with misoprostol.
Escumalha M; Gouveia C; Cunha M; Vale F; Machado MC
Pediatr Nurs; 2005; 31(3):228-31. PubMed ID: 16060589
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
Faucher P; Baunot N; Madelenat P
Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
[TBL] [Abstract][Full Text] [Related]
9. Comparison or oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion.
Mittal S; Agarwal S; Kumar S; Batra A
Indian J Med Res; 2005 Aug; 122(2):132-6. PubMed ID: 16177470
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of illegal abortions in Libreville Hospital, Gabon].
Mayi-Tsonga S; Diallo T; Litochenko O; Methogo M; Ndombi I
Bull Soc Pathol Exot; 2009 Oct; 102(4):230-2. PubMed ID: 19950540
[TBL] [Abstract][Full Text] [Related]
11. Motivations for using misoprostol for abortion outside the formal healthcare system in Colombia: a qualitative study of women seeking postabortion care in Bogotá and the Coffee Axis.
Ortiz J; Blades N; Prada E
Reprod Health; 2024 Jun; 21(1):76. PubMed ID: 38824533
[TBL] [Abstract][Full Text] [Related]
12. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.
Dahiya K; Mann S; Nanda S
Arch Gynecol Obstet; 2011 Jul; 284(1):59-63. PubMed ID: 20652288
[TBL] [Abstract][Full Text] [Related]
14. Misoprostol and illegal abortion in Fortaleza, Brazil.
Coêlho HL; Teixeira AC; Santos AP; Forte EB; Morais SM; La Vecchia C; Tognoni G; Herxheimer A
Lancet; 1993 May; 341(8855):1261-3. PubMed ID: 8098403
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical correlates of unsuccessful use of drugs to induce menstruation.
Mengue SS; Schenkel EP; Duncan BB; Schmidt MI
Contraception; 1998 Feb; 57(2):93-7. PubMed ID: 9589835
[TBL] [Abstract][Full Text] [Related]
16. Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion.
Kopp Kallner H; Fiala C; Gemzell-Danielsson K
Contraception; 2012 Apr; 85(4):394-7. PubMed ID: 22067756
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
[TBL] [Abstract][Full Text] [Related]
18. The knowledge, acceptability, and use of misoprostol for self-induced medical abortion in an urban US population.
Rosing MA; Archbald CD
J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):183-5. PubMed ID: 10846334
[TBL] [Abstract][Full Text] [Related]
19. Abortion failure after illegal use of misoprostol--a case report.
Rouzi AA
Eur J Contracept Reprod Health Care; 2010 Oct; 15(5):376-8. PubMed ID: 20863260
[TBL] [Abstract][Full Text] [Related]
20. Association between gestational age and induction-to-abortion interval in mid-trimester pregnancy termination using misoprostol.
Vitner D; Deutsch M; Paz Y; Khatib N; Baltiter T; Rosenberg S; Lowenstein L
Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):140-3. PubMed ID: 21507550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]